Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in Major Depressive Episodes of Bipolar Disorder
NCT07412132Phase 3Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in bipolar disorder (BD), sponsored by Universidade de São Paulo. Started Jan 2026; status: recruiting.
02
Drugs
lacosamide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT07412132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412132.